Coral Laboratories Q3 Results
- BSE: 524506
- NSE: -
- ISIN: INE683E01017
- Sector: Biotechnology & Drugs
BSE
489.40
11.40 (2.38%)
11.40 (2.38%)Volume494.00
Updated: Wed 11 Feb, 2026 | 15:56:48
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Coral Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 17.18 | 26.23 | -34.52% | 16.54 | 3.84% |
| Depreciation/ Amortization | 0.50 | 0.51 | -1.47% | 0.49 | 2.12% |
| Operating Income | 5.81 | 6.00 | -3.12% | 1.54 | 278.04% |
| Net Income | 6.14 | 6.38 | -3.69% | 2.16 | 184.94% |
| Other Operating Expenses Total | 3.82 | 6.24 | -38.71% | 5.01 | -23.71% |
| Net Income Before Taxes | 8.31 | 8.53 | -2.52% | 2.98 | 179.35% |
| Total Revenue | 22.99 | 32.23 | -28.68% | 18.08 | 27.15% |
| Selling/ General/ Admin Expenses Total | 3.38 | 3.93 | -13.92% | 2.98 | 13.64% |
| Diluted Normalized EPS | 17.20 | 17.86 | -3.70% | 6.19 | 178.01% |